Clinical and demographic features of patients
| Injection sclerotherapy (n=77) | Octreotide (n=73) | |
| Age (years) (median (range)) | 52 (30–83) | 57 (36–83) |
| M/F | 38/39 | 47/27 |
| Type of bleed | ||
| Index bleed (first variceal bleed) | 29 | 421-150 |
| Interval bleeds (second or subsequent variceal bleed) | 48 | 31 |
| Child’s grade | ||
| A | 11 | 12 |
| B | 25 | 22 |
| C | 41 | 39 |
| Cause of portal hypertension | ||
| Intrahepatic | ||
| Alcohol | 50 | 46 |
| CAH | 3 | 4 |
| Cryptogenic | 6 | 7 |
| Haemochromatosis | 0 | 2 |
| Hepatitis B and C | 0 | 1 |
| Sclerosing cholangitis | 6 | 3 |
| PBC | 9 | 6 |
| Sarcoidosis | 0 | 1 |
| Unkown | 2 | 3 |
| Extrahepatic | ||
| PVT | 1 | 0 |
CAH, chronic active hepatitis; PBC, primary biliary cirrhosis; PVT, portal vein thrombosis.
↵1-150 p<0.05.